These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17096681)

  • 1. Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage.
    Poluzzi E; Strahinja P; Vaccheri A; Vargiu A; Silvani MC; Motola D; Marchesini G; De Ponti F; Montanaro N
    Br J Clin Pharmacol; 2007 Mar; 63(3):346-55. PubMed ID: 17096681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial treatment of hypertension and adherence to therapy in general practice in Italy.
    Poluzzi E; Strahinja P; Vargiu A; Chiabrando G; Silvani MC; Motola D; Sangiorgi Cellini G; Vaccheri A; De Ponti F; Montanaro N
    Eur J Clin Pharmacol; 2005 Sep; 61(8):603-9. PubMed ID: 16082539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adherence to antihypertensive and lipid-lowering medications: a problem of public health, not yet resolved].
    Grosso G; Raciti T; Marventano S; Romeo I; Mistretta A
    Ann Ig; 2011; 23(2):173-84. PubMed ID: 21770233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive, antidiabetic and lipid-lowering treatment frequencies in France in 2010.
    Tuppin P; Ricci-Renaud P; de Peretti C; Fagot-Campagna A; Gastaldi-Menager C; Danchin N; Alla F; Allemand H
    Arch Cardiovasc Dis; 2013 May; 106(5):274-86. PubMed ID: 23769402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term persistence with antihypertensive drugs in new patients.
    Degli Esposti E; Sturani A; Di Martino M; Falasca P; Novi MV; Baio G; Buda S; Volpe M
    J Hum Hypertens; 2002 Jun; 16(6):439-44. PubMed ID: 12037702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential adherence to immunosuppressive over nonimmunosuppressive medications in kidney transplant recipients.
    Terebelo S; Markell M
    Transplant Proc; 2010 Nov; 42(9):3578-85. PubMed ID: 21094819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999-2002.
    Mirandola M; Andretta M; Corbari L; Sorio A; Nosè M; Barbui C
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):412-20. PubMed ID: 16287199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of cardiovascular events in Italian patients with early discontinuations of antihypertensive, lipid-lowering, and antidiabetic treatments.
    Corrao G; Zambon A; Parodi A; Merlino L; Mancia G
    Am J Hypertens; 2012 May; 25(5):549-55. PubMed ID: 22278212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence with treatment in newly treated middle-aged patients with essential hypertension.
    Perreault S; Lamarre D; Blais L; Dragomir A; Berbiche D; Lalonde L; Laurier C; St-Maurice F; Collin J
    Ann Pharmacother; 2005 Sep; 39(9):1401-8. PubMed ID: 16076920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study.
    Iskedjian M; Walker JH; Desjardins O; Robin AL; Covert DW; Bergamini MV; Einarson TR
    Curr Med Res Opin; 2009 Aug; 25(8):1879-88. PubMed ID: 19530975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization.
    Cooke CE; Lee HY; Tong YP; Haines ST
    Curr Med Res Opin; 2010 Jan; 26(1):231-8. PubMed ID: 19921965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of orlistat initiation on cardiovascular treatment use: a 6-year population-based cohort study.
    Czernichow S; Knol MJ; Fezeu L; Grobbee DE
    Eur J Prev Cardiol; 2012 Jun; 19(3):484-9. PubMed ID: 21464100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of cardiovascular absolute risk assessment on prescribing of antihypertensive and lipid-lowering medications: a cluster randomized controlled trial.
    Vagholkar S; Zwar N; Jayasinghe UW; Denney-Wilson E; Patel A; Campbell T; Harris MF
    Am Heart J; 2014 Jan; 167(1):28-35. PubMed ID: 24332139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes management in an Australian primary care population.
    Krass I; Hebing R; Mitchell B; Hughes J; Peterson G; Song YJ; Stewart K; Armour CL
    J Clin Pharm Ther; 2011 Dec; 36(6):664-72. PubMed ID: 21355875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.
    Mazzaglia G; Ambrosioni E; Alacqua M; Filippi A; Sessa E; Immordino V; Borghi C; Brignoli O; Caputi AP; Cricelli C; Mantovani LG
    Circulation; 2009 Oct; 120(16):1598-605. PubMed ID: 19805653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Awareness of albuminuria in an Italian population-based cohort of patients treated with hypoglycemic drugs.
    Degli Esposti L; Saragoni S; Buda S; Sturani A; Quintaliani G; Bartolucci S; Di Turi R; Lilli P; Didoni G; Degli Esposti E
    J Nephrol; 2012; 25(3):325-31. PubMed ID: 21748718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of physicians' management and communication ability on patients' persistence with antihypertensive medication.
    Tamblyn R; Abrahamowicz M; Dauphinee D; Wenghofer E; Jacques A; Klass D; Smee S; Eguale T; Winslade N; Girard N; Bartman I; Buckeridge DL; Hanley JA
    Arch Intern Med; 2010 Jun; 170(12):1064-72. PubMed ID: 20585073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients.
    Laliberté F; Nelson WW; Lefebvre P; Schein JR; Rondeau-Leclaire J; Duh MS
    Adv Ther; 2012 Aug; 29(8):675-90. PubMed ID: 22898791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Reiner Z; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):530-40. PubMed ID: 20577089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.